NIH Announces $50 Million Autism Research Initiative

The U.S. National Institutes of Health has unveiled a $50 million initiative aimed at advancing autism research through scientific collaboration and innovative studies. This multi-year effort seeks to deepen understanding of autism spectrum disorders by integrating genetic, environmental, and neurobiological data. Officials emphasize that the program is firmly rooted in evidence-based science to improve diagnostics and interventions.

FDA Official Addresses Autism Report Status

FDA Chief Marty Makary stated that an anticipated autism report has not yet been written, describing a Wall Street Journal story on the matter as premature. He indicated the report would be released within a month. Meanwhile, Kenvue's stock dropped following related news.

CDC reports autism prevalence rising to 1 in 36 children

October 04, 2025 Reported by AI

The Centers for Disease Control and Prevention has released new data showing that autism spectrum disorder affects 1 in 36 eight-year-old children, an increase from previous years. The findings, based on surveillance from 11 U.S. sites, highlight ongoing trends without identifying a single cause. Experts emphasize the need for continued research and support services.

Prenatal traffic pollution exposure tied to autism risk in boys

October 02, 2025 Reported by AI

A new study has linked prenatal exposure to traffic-related air pollution with an increased risk of autism spectrum disorder in boys. Researchers found that higher levels of black carbon during pregnancy were associated with a 1.5 times greater likelihood of autism diagnosis. The findings come from a cohort of over 1,400 children in the Netherlands.

Lawsuits claim Tylenol use in pregnancy causes autism

October 02, 2025 Reported by AI

More than 100 lawsuits have been filed against acetaminophen manufacturers, including Johnson & Johnson, alleging that the drug's use during pregnancy increases the risk of autism and ADHD in children. These legal actions stem from scientific studies showing associations between prenatal exposure and neurodevelopmental disorders. The cases highlight growing concerns over the safety of a widely used pain reliever.